Back to Journals » Vascular Health and Risk Management » Volume 14

Clinical potential of canagliflozin in cardiovascular risk reduction in patients with type 2 diabetes

Total article views   Abstract views HTML views PDF downloads Totals
6,394 Dovepress* 4,241 901+ 1,564 5,142
PubMed Central* 0 1,252 283 1,252
Totals 4,241 2,153 1,847 6,394
*Since 7 December 2018
+Since July 2016

View citations on PubMed Central and Google Scholar